Dosimetric comparison of two afterloaders and treatment planning systems in vaginal high-dose-rate brachytherapy

阴道高剂量率近距离放射治疗中两种后装式放射治疗机和治疗计划系统的剂量学比较

阅读:1

Abstract

PURPOSE: In treatment planning for high-dose-rate (HDR) single-channel vaginal cylinder brachytherapy, dose distribution along the cylinder is influenced by the anisotropy of the source. Differences in anisotropy are due to differences in source dimensions and characteristics. In this study, we compared HDR vaginal cylinder brachytherapy treatment plans from two afterloader/treatment planning systems. MATERIAL AND METHODS: Seventy-five plans with prescription to the surface were generated for cylinders in Varian BrachyVision and Elekta Oncentra. To understand the impact of source anisotropy on dose distribution to the surface of the cylinder, potential effect caused by differences in cylinder geometry between systems was eliminated by re-planning Varian cylinder using Elekta source model. Mean relative dose was calculated for each point as well as the dome and length of the cylinder. Related-samples Wilcoxon signed-rank tests were performed to compare the mean relative dose between systems. RESULTS: Treatment plans with VariSource iX source and cylinder demonstrated 16.2% lower (p < 0.001) dose at the tip compared to Elekta v.3. Average dose to the points along the dome of cylinder was 128.4% ±17.9% prescription dose with VariSource iX source and cylinder, and 99.9% ±4.3% with Elekta v.3 source and cylinder. For the same cylinder geometry, the effect of source characteristics produced up to 36.8% difference in dose homogeneity. When cylinder types were planned with the same source, there was no significant difference in dose distribution. CONCLUSIONS: This study demonstrates that the effect of source characteristics produced up to 37% difference in dose homogeneity when comparing two afterloader/treatment planning systems, independent of cylinder geometry. This insight on variation in dose surrounding source system is imperative for dosimetry considerations. Depending on the choice of afterloader, the extent of EQD(2) for tumor control versus normal tissue toxicity can vary.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。